Thus, novel miR-21/S100a8/NF-κB/NFAT pathway regulatory dysfunction might contribute to the progression of cardiac hypertrophy in aged subjects under hypertension pathophysiology. This evidence concerns the gene S100A8 and cardiac hypertrophy.